It has been reported that ABC transporters are associated with multiple aspects of cholesterol metabolism, such as baseline cholesterol levels, cholesterol kinetics, hypercholesterolemia, individual responses to dietary and pharmaceutical interventions, and an increased risk of gallstones (Rudkowska and Jones, 2008; Wang et al., 2022b). This evidence concerns the gene ABCG2 and gallstones.